Status: Open Not Enrolling
Investigator: Maen Abdelrahim
Study Coordinator:
Phone:
We propose a regimen of six months neoadjuvant lenvatinib in combination with transcatheter arterial chemoembolization (TACE) prior to liver transplantation in patients with hepatocellular carcinoma (HCC) beyond Milan Criteria. Clinical, outcome ... Read more >
